HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza.

Abstract
The longevity of the influenza virus-specific CD8+ T cell response following intranasal delivery of a synthetic lipopeptide was investigated and the characteristics and location of the cells associated with viral clearance examined. The lipopeptide, incorporating an epitope for CD8+ T cells and another for CD4+ T cells with the lipid moiety S-[2,3-bis(palmitoyloxy)propyl]cysteine (Pam2Cys) attached, induced potent and long-lived pulmonary protection. Both the lipopeptide and its largely unprotective non-lipidated counterpart elicited comparable numbers of CD8+ T cells in the spleen, which was the main location of the memory pool. However, the lipopeptide, unlike the non-lipidated peptide, also induced a substantial memory population that remained in the lungs and was rapidly activated upon viral challenge months later. These lipopeptide-induced lung-resident CD8+ T cells were also very similar in number and IFN-gamma-secreting potential to those induced by prior exposure to the virus itself and are likely mediators of initial viral clearance prior to recruitment from the expanding lymph node T cell pool. Significant clearing responses were demonstrated as late as 9 months post-lipopeptide vaccination. This study shows that CD8+ T cells primed by the lipopeptide are not only long-lived but can take up residence in the lung where they are important early mediators of pulmonary protection.
AuthorsGeorgia Deliyannis, Katherine Kedzierska, Yuk Fai Lau, Weiguang Zeng, Stephen J Turner, David C Jackson, Lorena E Brown
JournalEuropean journal of immunology (Eur J Immunol) Vol. 36 Issue 3 Pg. 770-8 (Mar 2006) ISSN: 0014-2980 [Print] Germany
PMID16435281 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Epitopes, T-Lymphocyte
  • Influenza Vaccines
  • Lipoproteins
  • Vaccines, Synthetic
  • Interferon-gamma
Topics
  • Administration, Intranasal
  • Animals
  • CD4-Positive T-Lymphocytes (immunology)
  • CD8-Positive T-Lymphocytes (immunology, metabolism)
  • Epitopes, T-Lymphocyte (administration & dosage, immunology)
  • Female
  • Humans
  • Immunologic Memory (immunology)
  • Influenza A virus (immunology)
  • Influenza Vaccines (administration & dosage, immunology)
  • Influenza, Human (immunology, prevention & control)
  • Interferon-gamma (immunology, metabolism)
  • Lipoproteins (administration & dosage, immunology)
  • Lung (immunology)
  • Lymph Nodes (immunology)
  • Mice
  • Mice, Inbred BALB C
  • Vaccines, Synthetic (administration & dosage, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: